San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy ...

Illumina (ILMN) announced it is collaborating with Nvidia (NVDA) to advance technology platforms for the analysis and interpretation of ...

The Truveta Genome Project aims to establish the world’s largest and most diverse database of genetic information.

Nvidia’s partnership with the gene sequencing company is one of several healthcare collaborations revealed Monday by the ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation ...

The pilot program is based on Illumina's upcoming proteomics assay, Illumina Protein Prep, powered by SOMAmer technology, a next-generation sequencing (NGS) based solution that will help scale access ...

Illumina raises Q4 and FY24 revenue outlook, expects solid margins, with projected 2024 EPS between $4.12 and $4.14.

A partnership with biotechnology firm Illumina Inc. aims to unlock insights from genomics data by combining Illumina’s ...

Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making the ...

Illumina, Inc., a leader in DNA sequencing and array technologies, has launched a pilot proteomics program analyzing 50,000 ...

Illumina (ILMN) announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard ...